Table 1.
Myocarditis and/or Pericarditis reports submitted to CAEFISS as of March 18, 2022.
| Age group: 18-29yrs | ||
|---|---|---|
| mRNA-1273 | BNT162b2 | |
| Cases | 180 | 99 |
| Age1 | 22 (19–25) | 22 (19–25) |
| Sex2 | ||
| Female | 24 (0.13) | 21 (0.21) |
| Male | 156 (0.87) | 78 (0.79) |
| Dose2 | ||
| 1 | 23 (0.13) | 34 (0.34) |
| 2 | 157 (0.87) | 65 (0.66) |
| BCD level2 | ||
| 1 | 47 (0.26) | 21 (0.21) |
| 2 | 122 (0.68) | 70 (0.71) |
| 3 | 11 (0.06) | 8 (0.08) |
| Age group: 30-39yrs | ||
| Cases | 49 | 44 |
| Age1 | 34 (31–36) | 34 (32–37) |
| Sex2 | ||
| Female | 19 (0.39) | 21 (0.48) |
| Male | 30 (0.61) | 23 (0.52) |
| Dose2 | ||
| 1 | 6 (0.12) | 19 (0.43) |
| 2 | 43 (0.88) | 25 (0.57) |
| BCD level2 | ||
| 1 | 14 (0.29) | 4 (0.09) |
| 2 | 32 (0.65) | 31 (0.70) |
| 3 | 3 (0.06) | 9 (0.20) |
1
Median (IQR)
2
n (proportion of total)